| Financial Year |
March 31 2023 |
| Monetary Funds |
354,929,173.81 |
| Held-for-trading Financial Assets |
330,000,000.00 |
| Notes Receivable |
14,243,210.36 |
| Accounts Receivable |
951,053,877.65 |
| Advances to Suppliers |
70,695,882.09 |
| Other Receivables |
58,342,467.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
196,509.69 |
| Inventories |
451,822,854.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,110,272.45 |
| Total Current Assets |
2,248,686,375.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,415,289.70 |
| Investment Properties |
17,075,732.30 |
| Fixed Assetes |
310,155,385.54 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,880,831.05 |
| R&D expenses |
49,846,459.82 |
| Goodwill |
5,337,069.77 |
| Long-Term Deferred and Prepaid Expenses |
2,389,693.73 |
| Deferred Income Tax Assets |
85,914,351.05 |
| Other Non-Current Assets |
53,897,457.06 |
| Sub-Total of Non-Current Assets |
1,056,558,184.40 |
| Total Assets |
3,305,244,559.97 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
98,410,520.00 |
| Accounts Payable |
331,622,832.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,018,783.82 |
| Taxes Payable |
4,219,724.85 |
| Interest Payable |
-- |
| Dividend Payable |
10,979.55 |
| Other payables |
32,642,828.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,824,841.78 |
| Other Current Liabilities |
7,523,861.40 |
| Sub-Total of Current Liabilities |
624,317,245.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
43,810,500.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,044,358.90 |
| Total Liabilities |
693,361,604.78 |
| Paid-In Capital(Or Share Stock) |
213,133,112.00 |
| Capital Surplus |
747,033,931.19 |
| Surplus Reserve |
121,040,266.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,272,944,375.61 |
| Minority Stockholder's Interest |
9,448,518.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,602,434,436.92 |
| Owner's Equity（Stockholder's Equity） |
2,611,882,955.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,305,244,559.97 |
